Videos

In Belgium, every year more than 25,000 people return to work after cancer treatment. Yet there are many employers who do not know how to react in such a situation. Elise Pattyn (Arteveldehogeschool) and her colleagues are working on tools to make the return to work smoother.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.

Chemotherapy affects the brains of patients. It can lead to cognitive complaints, stress, and fatigue. Michelle Melis achieves promising results with mindfulness in patients with breast cancer. 

What is the link between a smoothie and the analysis of cancer tumours? Well, Sebastiaan Vanuytven explains it smooth(l)y in this video

Melanoma is a very common and lethal type of skin cancer. Melanoma cells have a strange, yet effective defence mechanism called autophagy: they can manage to survive by eating parts of themselves. Monica Vara Perez tries to figure out this self-cannibalism mechanism in order to help defeat melanoma.

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.

Did you know that 1 in 100 people who develop cancer are under 18 years of age? In order to diagnose cancer, a surgical biopsy is often required. But Ruben Van Paemel and his colleagues want to change this. They want to detect cancer in children by taking a simple blood sample.

Did you know that cancer researchers draw inspiration from applications such as Amazon, Facebook and even Tinder? Armed with a supercomputer, Celine Everaert, like these applications, processes large amounts of data. Not to sell books or to help people get on a date, but to offer cancer patients personalised treatments.

Did you know that breast cancer is the second most common cancer for women, affecting 1.7 million women worldwide? In her research Ovia Margaret Thirukkumaran is trying to decipher how cancer cells communicate and develop resistance against drugs in so called HER 2 breast cancer, a very aggressive form of breast cancer.

While an organ transplant will often save the life of a patient, it also leads to a higher risk of developing cancer. Nena Testelmans (KU Leuven) is determined to help unravel why transplants might induce cancer in patients.